alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 13**  **- 8030** 

CHARLES R . MORRIS , Petitioner

- Appellant ,
v. HAROLD W. CLARKE, Director , Respondent

- Appellee
.

Appeal from the United States District Court for the Eastern District of Virginia , at Alexandria
. Liam O’Grady , District Judge. ( 1:13

- cv - 00629

- LO

- TCB )

Submitted : April 24 , 2014 Decided: April 28, 2014

Before NIEMEYER, SHEDD , and FLOYD , Circuit Judges.

Dismissed by un published per curiam opinion
. Charles R. Morris, Appellant Pro Se.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Charles R. Morris seeks to appeal the district court’s order dismissing as untimely his 28 U.S.C. § 2254 (2012) petition. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C.
§ 2253(c)(1) (A) (2012) . A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2012). When the district court denies relief on procedural grounds, the prisoner must demonstrate both that the dispositive procedural ruling is debatable, and that the petition states a debatable claim of the denial of a constitutional right. Slack v. McDaniel , 529 U.S. 473, 484

- 85 (2000)
. We have independently reviewed the record and conclude that Morris has not made the requisite showing. Accordingly, we deny a certificate of appealability, deny leave to proceed in forma pauperis, and di smiss the appeal
. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before th is court and argument would not aid the decisional process.
DISMISSED
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. Con. Res. 5 Engrossed in Senate (ES)]

  1st Session
S. CON. RES. 5

_______________________________________________________________________

                         CONCURRENT RESOLUTION

Whereas at the heart of the Oslo peace process lies the basic, irrevocable 
        commitment made by Palestinian Chairman Yasir Arafat that, in his words, 
        ``all outstanding issues relating to permanent status will be resolved 
        through negotiations'';
Whereas resolving the political status of the territory controlled by the 
        Palestinian Authority while ensuring Israel's security is one of the 
        central issues of the Israeli-Palestinian conflict;
Whereas a declaration of statehood by the Palestinians outside the framework of 
        negotiations would, therefore, constitute a most fundamental violation 
        of the Oslo process;
Whereas Yasir Arafat and other Palestinian leaders have repeatedly threatened to 
        declare unilaterally the establishment of a Palestinian state;
Whereas the unilateral declaration of a Palestinian state would introduce a 
        dramatically destabilizing element into the Middle East, risking Israeli 
        countermeasures, a quick descent into violence, and an end to the entire 
        peace process; and
Whereas in light of continuing statements by Palestinian leaders, United States 
        opposition to any unilateral Palestinian declaration of statehood should 
        be made clear and unambiguous: Now, therefore, be it
    Resolved by the Senate (the House of Representatives concurring), 
That--
            (1) the final political status of the territory controlled 
        by the Palestinian Authority can only be determined through 
        negotiations and agreement between Israel and the Palestinian 
        Authority;
            (2) any attempt to establish Palestinian statehood outside 
        the negotiating process will invoke the strongest congressional 
        opposition; and
            (3) the President should unequivocally assert United States 
        opposition to the unilateral declaration of a Palestinian 
        State, making clear that such a declaration would be a grievous 
        violation of the Oslo accords and that a declared state would 
        not be recognized by the United States.

            Passed the Senate March 11, 1999.

            Attest:

                                                             Secretary.
106th CONGRESS

  1st Session

                             S. CON. RES. 5

_______________________________________________________________________

                         CONCURRENT RESOLUTION

Expressing congressional opposition to the unilateral declaration of a 
  Palestinian state and urging the President to assert clearly United 
    States opposition to such a unilateral declaration of statehood.
```
<Page>


                                                                    Exhibit 21.1


                         SUBSIDIARIES OF THE REGISTRANT


NAME OF SUBSIDIARY                                 JURISDICTION OF INCORPORATION
Manhattan Bagel Company, Inc.                      New Jersey
Chesapeake Bagel Franchise Corp.                   New Jersey
      (f/k/a CBB Acquisition Corp.)
Willoughby's Incorporated                          Connecticut
MBC Genesee, LLC                                   New York
New World ENBCDEB Corp.                            New York
Einstein and Noah Corp.                            Delaware
      (f/k/a Einstein Acquisition Corp.)
Einstein/Noah Bagel Partners, Inc.                 California
I. & J. Bagel, Inc.                                California
Paragon Bakeries, Inc.                             New Jersey
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 8, 2011, Siegfried (USA), 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug
ScheduleGamma Hydroxybutyric Acid (2010)
IDihydromorphine (9145)
IHydromorphinol (9301)
IMethylphenidate (1724)
IIAmobarbital (2125)
IIPentobarbital (2270)
IISecobarbital (2315)
IICodeine (9050)
IIOxycodone (9143)
IIHydromorphone (9150)
IIHydrocodone (9193)
IIMethadone (9250)
IIMethadone intermediate (9254)
IIDextropropoxyphene, bulk (non-dosage forms) (9273)
IIMorphine (9300)
IIOripavine (9330)
IIOxymorphone (9652)
II
 The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than March 19, 2012. Dated: January 6, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2012-679 Filed 1-13-12; 8:45 am] BILLING CODE 4410-09-P
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**513 KA 14-00376**  PRESENT: CENTRA, J.P., CARNI, SCONIERS, VALENTINO, AND WHALEN, JJ.

THE PEOPLE OF THE STATE OF NEW YORK, RESPONDENT,

V MEMORANDUM AND ORDER
RICHARD M. LEONARD, DEFENDANT-APPELLANT. (APPEAL NO. 2.)

EASTON THOMPSON KASPEREK SHIFFRIN LLP, ROCHESTER (BRIAN SHIFFRIN OF COUNSEL), FOR DEFENDANT-APPELLANT.
SANDRA DOORLEY, DISTRICT ATTORNEY, ROCHESTER (ROBERT J. SHOEMAKER OF COUNSEL), FOR RESPONDENT.

Appeal, by permission of a Justice of the Appellate Division of the Supreme Court in the Fourth Judicial Department, from an order of the Monroe County Court (James J. Piampiano, J.), entered January 29, 2014. The order denied the motion of defendant seeking to vacate the judgment of conviction pursuant to CPL 440.10.
It is hereby ORDERED that the order so appealed from is unanimously affirmed.

Same memorandum as in People v Leonard ([appeal No. 1] ___ AD3d ___ [June 19, 2015]).

Entered: June 19, 2015 Frances E. Cafarell Clerk of the Court
<PAGE>
 
                                                                   Exhibit 23(B)
                                                                   -------------



                          INDEPENDENT AUDITORS' CONSENT


The Board of Directors
Iroquois Bancorp, Inc.:

We consent to incorporation by reference in the Registration Statement No.
33-36828, on Form S-8 of Iroquois Bancorp, Inc. of our report dated March 10,
1999 relating to the statement of net assets available for benefits, with fund
information of the Iroquois Bancorp, Inc. 401(k) Savings Plan as of December 31,
1998 and the related statement of changes in net assets available for benefits,
with fund information for the year ended December 31, 1998 and related schedules
as of and for the year ended December 31, 1998, which report appears in the
December 31, 1998 annual report on Form 10-K of Iroquois Bancorp, Inc.



     /s/The Fagliarone Group, P.C.        
----------------------------------
The Fagliarone Group, P.C.

Syracuse, New York
March 22, 1999
#### STATE ex rel. Raymond ROSS v. Warden DEES.

No. 89-KH-0363.

Supreme Court of Louisiana.

Feb. 17, 1989.

In re Ross, Raymond;—Plaintiff(s); applying for supervisory and/or remedial writ; Parish of Terrebonne, 32nd Judicial District Court, Div. “B”.

Denied. The district court has no record of a habeas petition filed on or about February 1, 1989.
<PAGE>

                                                                    EXHIBIT 99.1



                                  CERTIFICATION


         Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.
Section 1350, as adopted), Gary J. Sbona, Chief Executive Officer of Verity,
Inc. (the "Company"), and Todd K. Yamami, Chief Financial Officer of the
Company, each hereby certify that, to the best of their knowledge:

1.  The Company's Annual Report on Form 10-K for the period ended May 31, 2002,
and to which this Certification is attached as Exhibit 99.1 (the "PERIODIC
REPORT"), fully complies with the requirements of section 13(a) or section 15(d)
of the Securities Exchange Act of 1934, and

2.  The information contained in the Periodic Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

         IN WITNESS WHEREOF, the undersigned have set their hands hereto as of
the 16th day of August, 2002.



    /s/ GARY J. SBONA
    -----------------------------------------
    Gary J. Sbona, CHIEF EXECUTIVE OFFICER



    /s/ TODD K. YAMAMI
    -----------------------------------------
    Todd K. Yamami, CHIEF FINANCIAL OFFICER
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2447 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2447

 To extend and modify the temporary reduction of duty on propiconazole 
                               technical.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 29, 2009

  Mr. Cornyn introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To extend and modify the temporary reduction of duty on propiconazole 
                               technical.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROPICONAZOLE TECHNICAL.

    (a) In General.--Heading 9902.29.80 of the Harmonized Tariff 
Schedule of the United States (relating to 1-[[2-(2,4-dichlorophenyl)-
4-propyl-1,3-dioxolan-2-yl]-methyl]-1H-1,2,4-triazole) is amended--
            (1) by striking ``Free'' and inserting ``5.2%''; and
            (2) by striking ``12/31/2009'' and inserting ``12/31/
        2011''.
    (b) Effective Date.--The amendments made by subsection (a) apply to 
goods entered, or withdrawn from warehouse for consumption, on or after 
the 15th day after the date of the enactment of this Act.
                                 <all>
```
Skip to main content (Press Enter).
 News
    
        Photos

    Week in Photos

    Air Force TV

    Commentaries

    Features

    Art

    About Us
    
        Air Force Senior Leaders
    
        SECAF

    CSAF

    CMSAF

    Biographies

    Fact Sheets

    SECAF Reading List

    CSAF Leadership Library
    
        CSAF Leadership Library 2022

    CSAF Leadership Library 2021

    CSAF Reading List Pre-2020 Archive
    
        2018 CSAF Reading List

    2017 CSAF Reading List

    2016 CSAF Reading List

    CSAF Leadership Library 2023

    CMSAF Leadership Library

    50 Years of the CMSAF

    Adjunct Professors

    Air Force Strategic Documents

    Arctic Strategy

    Empowered Airmen

    State Licensure Portability

    Careers

    AF Federal Advisory Committees

    AF 75th Anniversary

    Policy Updates

    AF Content Management

    Contact Us

    AF Sites
    
        Site RegistrationU.S. Air Force LogoAir Force

        Policy UpdatesNewsroomReoptimizationBIOGRAPHIESAF Senior Leaders

    HomeNewsCommentaries     Explosive Ordnance Disposal technicians
        
            Commentaries
 Keyword
 Type Select a CategoryTop StoriesMission/TrainingFeaturesSecretary of the AFAF Chief of StaffChief Master Sgt. of the AFCommentariesSequestration NewsSpace/TechnologyHumanitarianAFSO 21Women's History Month 1-15EnvironmentalWarrior CareDiversityDignified TransferSafetyHeritageAir Force FamilyPersonnel MattersCommander's Call TopicsHaiti Earthquake ReliefDon't Ask Don't TellSuicide PreventionWarrior GamesEnergyAircraftEtchbergerSexual AssaultOperation TomodachiOperation Odyssey Dawn2011 Appropriations InformationHurricane Irene9/11AFAWeek in PhotosThrough Airmen's EyesThrough AIrmen's Eyes FeaturesThrough Their Words2012 Appropriations InformationAfrican American History MonthAfrican American Heritage Month 1-15African American Heritage Month 16-29Fiscal Year BudgetAir Force StoriesColorado WildfireChief of Staff ArchiveHurricane IsaacAFA 2012APP RSSAPP Airman VisualsExpeditionary OperationsHurricane SandyTransition GPSAir Force in SpaceSports/RecreationH1N1Women's History Month 16-30Oklahoma Tornado ReliefMemorial DayCOVID-19 CommentariesCOVID-19
 RecentOldestTitle A > ZTitle Z > A
 Dec. 14, 2015Finding strength, resiliency through Air Force family
        Airman 1st Class Christopher Thornbury said his Air Force family has been with him for over a year and helped him through the loss of his son, Emmitt Alan Thornbury.  Quick Links
AccessibilityContact UsEqual OpportunityFOIA | Privacy | Section 508Information QualityInspector GeneralJAG Court-Martial DocketLink DisclaimerNo FEAR ActOpen GovernmentOSI Tip LinePlain LanguageQuestionsResilienceRSSSite MapVeterans Crisis LineCareers
Join the Air ForceAir Force BenefitsAir Force CareersAir Force ReserveAir National GuardCivilian ServiceConnect
            Get Social with Us
            
            Official United States Air Force Website
    Hosted by Defense Media Activity - WEB.mil
#### Sabrina Ann MATTINGLY, Individually and As the Natural Tutrix of Her Minor Child, Matthew T. Landry v. The STATE of Louisiana, THROUGH the DEPARTMENT OF HEALTH AND HUMAN RESOURCES, et al.

No. 87-C-1520.

Supreme Court of Louisiana.

Sept. 25, 1987.

In re Louisiana, State of; Health and Human Res. Dept.; Travelers Insurance *462Co.; applying for writ of certiorari and/or review; to the Court of Appeal, First Circuit, No. CA86 0459; Parish of Lafourche, 17th Judicial District Court, Div. “D”, No. 53418.

Prior report: La.App., 509 So.2d 82.

Denied.

CALOGERO, J., would grant the writ.
<PAGE>   1
                                                                    EXHIBIT 22.1


ReSound-Viennatone
Hortechnologie AG
Austria

ReSound-Viennatone SARL
France

ReSound-Viennatone
Hortechnologie AG & Co. OHG
Germany

ReSound GmbH
Hortechnologie
Germany

ReSound Deutschland GmbH
Germany

ReSound Ireland Limited
Ireland

ReSound Holdings Limited
Ireland

ReSound Ireland Sales Limited
Ireland

ReSound BV
Netherlands

ReSound AB
Sweden

ReSound-Viennatone Ltd.
United Kingdom

ReSound Pty Ltd.
Australia

ReSound Ltd.
Hong Kong

ReSound Asia, Limited
British Virgin Islands

ReSound AUTAC GmbH
Switzerland
Exhibit 32.2 

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350,        AS ADOPTED PURSUANT TO        SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

          In connection with the Quarterly Report of KeyOn Communications Holdings, Inc. (the “Company”) on Form 10-Q/A for the quarterly period ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Annette Eggert, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the        Sarbanes-Oxley Act of 2002, that to my knowledge: 

|   |   |                                                                                                                                                 |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (1)    | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                |
|   |   |                                                                                                                                                 |
|   | (2)    | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

|                    |      |                          |   |
|-------------------------|-----------|-------------------------------|--------|
| Date: November 16, 2009 | By:  | /s/ Annette Eggert            |   |
|                    |      |                               |   |
|                    |      | Annette Eggert                |   |
|                    |      | Chief Financial Officer       |   |
|                    |      | (Principal Financial Officer) |   |

----
```

[Federal Register Volume 77, Number 196 (Wednesday, October 10, 2012)]
[Rules and Regulations]
[Page 61513]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25016]

=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION

16 CFR Part 1101

Information Disclosure Under Section 6(b) of the Consumer Product 
Safety Act

CFR Correction

0
In Title 16 of the Code of Federal Regulations, Part 1000 to End, 
revised as of January 1, 2012, on page 147, in Sec.  1101.25 (a) and 
(b), the words ``5 working'' are corrected to read ``5''.

[FR Doc. 2012-25016 Filed 10-9-12; 8:45 am]
BILLING CODE 1505-01-D
```
EXHIBIT 32.1





CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER


PURSUANT TO 18 U.S.C. 1350,


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





I, Kam Shah, Chief Executive Officer and Chief Financial Officer of Webtradex International, Corp. (the "Company"), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:





(1) The Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








/s/ Kam Shah


Kam Shah


Chief Executive Officer


Chief Financial Officer





Date: August 3, 2012





___________


This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.





A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
UNITED STATES ENVIRONMEN TAL PROTECTION AGENCY WASHINGTON, D.C. 20460

OFFICE OF

CHEMICAL SAFETY AND

POLLUTION PREVENTION

September 8, 2010

MEMORANDUM

SUBJECT: Active ingredient inadvertently omitted from Zinc, Zinc Salts and Zeolites Registration Review documents.

FROM: Eliza Blair, Chemical Review Manager Regulatory Management Branch II Antimicrobials Division (7510P)

TO: Mark Hartman, Branch Chief Regulatory Management Branch II Antimicrobials Division (7510P)

THRU: Lance Wormell, Team Leader Regulatory Management Branch II Antimicrobials Division (7510P)

This document serves as a notification that the active ingredient Zi nc Sulfate, PC Code 089001, was inadvertently omitted from the following documents for Registration Review Case # 4099 (Zinc, Zinc Salts and Zeolites). There is currently one antimicrobial product containing Zinc Sulfate (EPA Registration # 1258-1329).

In the Preliminary and Final Work Plans, EPA stated that data from Zinc Oxide could be bridged with the other ac tive ingredients in the case. The a ddition of Zinc Sulfate to the case does not change EPA’s position and the listed data EPA intends to require and risk assessments EPA intends to conduct have not changed. The Zinc Sulfate active ingredient and product will be subject to the Registration Review process with the rest of the Zi nc, Zinc Salts and Zeolites case, including the upcomi ng Data Call-In.

For questions about Zinc Sulfate’s antimicr obial uses, please c ontact Eliza Blair (703- 308-7279, blair.eliza@epa.gov).